- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BMY
Recent news which mentions BMY
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
October 10, 2022
Tickers
BMY
From Benzinga
Will Chart Analysts Notice Bad Omen on Bristol-Myers Squibb's Chart
October 10, 2022
Tickers
BMY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
From Benzinga
Want to Buy the Dip? This Real Estate Stock Is a Smart Buy
October 07, 2022
From Motley Fool
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
From Benzinga
There are early signs that the bear market is going into hibernation
October 06, 2022
From MarketWatch
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors
October 06, 2022
From Benzinga
3 Stocks Savvy Investors Are Buying Hand Over Fist
October 06, 2022
From Motley Fool
From InvestorPlace
Best Stocks 2022: These 3 Factors Can Send Sonic Automotive (SAH) Stock Soaring in Q4
October 04, 2022
From InvestorPlace
From Benzinga
Bear Market Bargains: 3 Dividend Stocks to Buy Now
October 03, 2022
From Motley Fool
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
Bear Market: 2 Safe Stocks to Buy Right Now
September 28, 2022
From Motley Fool
From Benzinga
Bristol-Myers Squibb, Cash, Cheniere Energy And This Tech Company Are CNBC's Final Trades
September 23, 2022
From Benzinga
Salesforce Is Among Thursday's CNBC 'Fast Money' Final Trades
September 22, 2022
From Benzinga
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
September 22, 2022
From Benzinga
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
From InvestorPlace
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
Amazon, Target And 3 Other Stocks Insiders Are Selling
September 19, 2022
From Benzinga
Bristol Myers' Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting
September 19, 2022
Tickers
BMY
From Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
From InvestorPlace
US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1%
September 19, 2022
From Benzinga
AutoZone, bluebird bio And 3 Stocks To Watch Heading Into Monday
September 19, 2022
From Benzinga
3 Stocks to Buy and Hold Forever
September 17, 2022
From Motley Fool
Why Ventyx Biosciences Zoomed Nearly 60% Higher This Week
September 16, 2022
From Motley Fool
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.